Home › Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

US Patent 10793894 · Granted Oct 6, 2020

Estimated economic value: $161,179,000 ⓘ

Assignee